Skip to content
Parakho

Divis Laboratories Ltd

NSE DIVISLABBSE 532488divislabs.com

Q1 FY27, unaudited

Revenue
₹3,080.00 Cr
Profit after tax
₹902.00 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year ago6M FY26
Revenue from operations3,080.00+27.80%2,831.00
Other income64.00−46.22%155.00
Total income3,144.00+24.32%2,986.00
Employee benefit expense408.00+20.00%381.00
Finance costs6.00+100.00%6.00
Depreciation & amortisation133.00+18.75%120.00
Total expenses1,964.00+9.35%2,023.00
Profit before tax1,180.00+60.98%963.00
Tax expense278.00+47.87%212.00
Profit after tax902.00+65.50%751.00
Total comprehensive income904.00+64.96%750.00
Earnings per share
Earnings per share, basic₹33.95₹28.31
Earnings per share, diluted₹33.95₹28.31

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

6M FY26 — from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Divi's Laboratories reported consolidated total income of ₹3,144 crores for Q1 FY27 compared to ₹2,529 crores a year earlier, with profit after tax at ₹902 crores versus ₹545 crores in the same period last year. Management said standalone revenue grew 10% on a constant currency basis, with Custom Synthesis contributing 60% of revenue and Generics 40%. Management also discussed elevated solvent costs, a three-month rolling inventory strategy to secure supply, and progress on validation batches across peptide, generic and custom synthesis projects.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 30 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 10 Aug 2026.